Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sin3a
|
ENSMUSG00000042557.8 | transcriptional regulator, SIN3A (yeast) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_57075290_57075441 | Sin3a | 27 | 0.963135 | 0.52 | 4.1e-05 | Click! |
chr9_57074273_57074704 | Sin3a | 850 | 0.475825 | 0.46 | 4.4e-04 | Click! |
chr9_57073617_57073980 | Sin3a | 1540 | 0.255995 | 0.42 | 1.6e-03 | Click! |
chr9_57076487_57077201 | Sin3a | 216 | 0.900896 | 0.38 | 4.1e-03 | Click! |
chr9_57075968_57076382 | Sin3a | 201 | 0.908272 | 0.35 | 9.5e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_33600072_33600973 | 61.56 |
Gm37618 |
predicted gene, 37618 |
16310 |
0.15 |
chr15_36643311_36643471 | 24.89 |
Gm6704 |
predicted gene 6704 |
13522 |
0.13 |
chr1_33617278_33617619 | 21.11 |
Gm37618 |
predicted gene, 37618 |
616 |
0.67 |
chr7_133710940_133711141 | 18.46 |
Uros |
uroporphyrinogen III synthase |
968 |
0.37 |
chr5_143731658_143732384 | 18.38 |
Usp42 |
ubiquitin specific peptidase 42 |
259 |
0.91 |
chr1_9784412_9784711 | 18.08 |
1700034P13Rik |
RIKEN cDNA 1700034P13 gene |
783 |
0.55 |
chr2_174329445_174331091 | 17.87 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chr2_48949106_48950119 | 16.86 |
Mbd5 |
methyl-CpG binding domain protein 5 |
89 |
0.8 |
chr7_133710663_133710880 | 15.96 |
Uros |
uroporphyrinogen III synthase |
699 |
0.49 |
chr17_34898151_34899707 | 15.51 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr8_108703603_108704102 | 15.27 |
Zfhx3 |
zinc finger homeobox 3 |
752 |
0.73 |
chr9_63757305_63758776 | 14.22 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr9_44881205_44881917 | 13.81 |
Gm39326 |
predicted gene, 39326 |
167 |
0.6 |
chr8_70609185_70610414 | 12.74 |
Gm45546 |
predicted gene 45546 |
626 |
0.42 |
chr7_133710460_133710636 | 12.54 |
Uros |
uroporphyrinogen III synthase |
476 |
0.63 |
chr11_69096542_69097348 | 12.31 |
Per1 |
period circadian clock 1 |
1728 |
0.15 |
chr9_100643446_100643943 | 12.03 |
Stag1 |
stromal antigen 1 |
58 |
0.97 |
chr15_96286955_96287696 | 11.59 |
Arid2 |
AT rich interactive domain 2 (ARID, RFX-like) |
193 |
0.94 |
chr11_78069241_78069397 | 11.56 |
Mir144 |
microRNA 144 |
3686 |
0.09 |
chr17_88065293_88066116 | 11.49 |
Fbxo11 |
F-box protein 11 |
413 |
0.86 |
chr15_36643569_36643757 | 10.75 |
Gm6704 |
predicted gene 6704 |
13794 |
0.13 |
chr9_109094576_109096217 | 10.60 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr1_86525613_86527056 | 10.48 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr14_14351950_14353283 | 10.47 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr8_120486990_120488549 | 10.43 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr5_121545189_121545856 | 10.39 |
Adam1a |
a disintegrin and metallopeptidase domain 1a |
40 |
0.44 |
chr4_88032518_88033581 | 10.21 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
232 |
0.71 |
chr7_45728040_45728346 | 10.06 |
Fam83e |
family with sequence similarity 83, member E |
2334 |
0.1 |
chr4_141750503_141750994 | 10.05 |
Agmat |
agmatine ureohydrolase (agmatinase) |
4076 |
0.15 |
chr19_41482494_41483686 | 9.95 |
Lcor |
ligand dependent nuclear receptor corepressor |
61 |
0.98 |
chr11_87358280_87359463 | 9.89 |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
152 |
0.93 |
chr2_106692893_106694599 | 9.74 |
Mpped2 |
metallophosphoesterase domain containing 2 |
477 |
0.85 |
chr15_79690079_79691459 | 9.43 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr17_28800512_28801462 | 9.27 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
103 |
0.88 |
chr3_101552255_101552604 | 9.21 |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
25131 |
0.16 |
chrX_42067696_42069057 | 9.05 |
Xiap |
X-linked inhibitor of apoptosis |
22 |
0.98 |
chr9_65826224_65827697 | 9.02 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr1_193012104_193012255 | 8.85 |
Syt14 |
synaptotagmin XIV |
23465 |
0.14 |
chr13_63564531_63566515 | 8.79 |
Ptch1 |
patched 1 |
212 |
0.91 |
chr10_80576603_80578409 | 8.76 |
Klf16 |
Kruppel-like factor 16 |
185 |
0.86 |
chr10_75706468_75706630 | 8.70 |
Cabin1 |
calcineurin binding protein 1 |
6174 |
0.14 |
chr1_156987024_156987430 | 8.68 |
4930439D14Rik |
RIKEN cDNA 4930439D14 gene |
47389 |
0.1 |
chr7_4739300_4740219 | 8.65 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr17_74294454_74295055 | 8.62 |
Memo1 |
mediator of cell motility 1 |
36 |
0.96 |
chr7_25686729_25687529 | 8.60 |
Tgfb1 |
transforming growth factor, beta 1 |
127 |
0.91 |
chr2_18677029_18677615 | 8.59 |
Bmi1 |
Bmi1 polycomb ring finger oncogene |
42 |
0.96 |
chr1_166002288_166003185 | 8.53 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chrX_48343022_48344334 | 8.53 |
Bcorl1 |
BCL6 co-repressor-like 1 |
92 |
0.97 |
chr9_70842752_70843019 | 8.48 |
Gm3436 |
predicted pseudogene 3436 |
9691 |
0.21 |
chrX_142680720_142682167 | 8.47 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr6_38875559_38876242 | 8.33 |
Hipk2 |
homeodomain interacting protein kinase 2 |
23 |
0.9 |
chr4_127021472_127021942 | 8.27 |
Sfpq |
splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) |
383 |
0.77 |
chr17_78199734_78201570 | 8.03 |
Crim1 |
cysteine rich transmembrane BMP regulator 1 (chordin like) |
267 |
0.74 |
chr11_77983926_77984968 | 8.01 |
Phf12 |
PHD finger protein 12 |
1645 |
0.25 |
chr5_134913432_134913583 | 7.99 |
Cldn13 |
claudin 13 |
2019 |
0.15 |
chr2_65801788_65801939 | 7.96 |
BX284648.1 |
sodium channel, voltage-gated, type II, alpha (Scn2a) pseudogene |
39666 |
0.14 |
chr6_138424907_138425582 | 7.94 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr2_92183514_92184054 | 7.93 |
Phf21a |
PHD finger protein 21A |
322 |
0.88 |
chr14_121731933_121732115 | 7.92 |
Dock9 |
dedicator of cytokinesis 9 |
6837 |
0.27 |
chr15_35490089_35490249 | 7.91 |
Gm24771 |
predicted gene, 24771 |
2769 |
0.32 |
chr3_100488535_100489982 | 7.86 |
Tent5c |
terminal nucleotidyltransferase 5C |
60 |
0.85 |
chr2_44926591_44927289 | 7.85 |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
209 |
0.96 |
chr13_45389281_45390472 | 7.69 |
Mylip |
myosin regulatory light chain interacting protein |
134 |
0.97 |
chr4_46450476_46451941 | 7.58 |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
306 |
0.86 |
chr1_181211252_181211896 | 7.41 |
Wdr26 |
WD repeat domain 26 |
137 |
0.94 |
chr11_97362594_97363225 | 7.38 |
Socs7 |
suppressor of cytokine signaling 7 |
358 |
0.82 |
chr15_81585272_81586453 | 7.36 |
Gm23880 |
predicted gene, 23880 |
271 |
0.52 |
chr18_39489335_39489856 | 7.35 |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
251 |
0.95 |
chr2_170130477_170131578 | 7.32 |
Zfp217 |
zinc finger protein 217 |
193 |
0.97 |
chr11_88068171_88069196 | 7.31 |
Vezf1 |
vascular endothelial zinc finger 1 |
404 |
0.76 |
chr4_140701770_140702866 | 7.24 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr2_25982690_25983958 | 7.21 |
Camsap1 |
calmodulin regulated spectrin-associated protein 1 |
42 |
0.97 |
chr11_107469708_107471023 | 7.15 |
Pitpnc1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
334 |
0.82 |
chr14_25606696_25608421 | 7.13 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
201 |
0.95 |
chr6_72389979_72390703 | 7.09 |
Vamp8 |
vesicle-associated membrane protein 8 |
362 |
0.76 |
chr2_153529370_153530642 | 7.09 |
Nol4l |
nucleolar protein 4-like |
35 |
0.98 |
chr17_57199772_57199923 | 7.09 |
Tnfsf14 |
tumor necrosis factor (ligand) superfamily, member 14 |
5670 |
0.12 |
chr13_55570569_55571325 | 7.06 |
Fam193b |
family with sequence similarity 193, member B |
153 |
0.9 |
chr2_28005306_28005501 | 7.02 |
Col5a1 |
collagen, type V, alpha 1 |
12038 |
0.19 |
chr12_76371019_76371219 | 6.89 |
Zbtb1 |
zinc finger and BTB domain containing 1 |
853 |
0.39 |
chr6_47454182_47454487 | 6.89 |
Cul1 |
cullin 1 |
14 |
0.5 |
chr3_103914017_103915242 | 6.87 |
Rsbn1 |
rosbin, round spermatid basic protein 1 |
62 |
0.95 |
chr5_100498242_100499138 | 6.86 |
Lin54 |
lin-54 homolog (C. elegans) |
57 |
0.95 |
chr19_46038782_46039575 | 6.85 |
Ldb1 |
LIM domain binding 1 |
303 |
0.84 |
chr5_103753230_103754272 | 6.84 |
Aff1 |
AF4/FMR2 family, member 1 |
411 |
0.87 |
chr13_111894842_111895036 | 6.76 |
Gm9025 |
predicted gene 9025 |
10762 |
0.15 |
chr19_4859073_4859231 | 6.72 |
Ctsf |
cathepsin F |
141 |
0.89 |
chr10_43479277_43480054 | 6.70 |
Bend3 |
BEN domain containing 3 |
525 |
0.71 |
chr13_37825583_37827437 | 6.70 |
Rreb1 |
ras responsive element binding protein 1 |
195 |
0.94 |
chr1_75445167_75446076 | 6.62 |
Gmppa |
GDP-mannose pyrophosphorylase A |
3397 |
0.11 |
chr11_79961869_79962916 | 6.59 |
Utp6 |
UTP6 small subunit processome component |
2 |
0.97 |
chr17_34836344_34837687 | 6.58 |
Dxo |
decapping exoribonuclease |
4 |
0.52 |
chr17_10318832_10319291 | 6.58 |
Qk |
quaking |
300 |
0.92 |
chr15_98108351_98109101 | 6.49 |
Pfkm |
phosphofructokinase, muscle |
260 |
0.87 |
chr18_24158931_24159082 | 6.49 |
Ino80c |
INO80 complex subunit C |
37053 |
0.15 |
chr5_122501856_122502977 | 6.43 |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
191 |
0.88 |
chr7_127026546_127028177 | 6.39 |
Maz |
MYC-associated zinc finger protein (purine-binding transcription factor) |
324 |
0.58 |
chr5_118560415_118560665 | 6.37 |
Med13l |
mediator complex subunit 13-like |
139 |
0.95 |
chr5_149229091_149229712 | 6.32 |
2310047D07Rik |
RIKEN cDNA 2310047D07 gene |
1931 |
0.18 |
chr2_72979541_72979824 | 6.26 |
Sp3os |
trans-acting transcription factor 3, opposite strand |
166 |
0.74 |
chr6_140623130_140624606 | 6.23 |
Aebp2 |
AE binding protein 2 |
179 |
0.93 |
chr3_136669841_136670888 | 6.21 |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isoform |
240 |
0.94 |
chr10_96616594_96617900 | 6.19 |
Btg1 |
BTG anti-proliferation factor 1 |
241 |
0.93 |
chr8_71702154_71702388 | 6.15 |
B3gnt3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
482 |
0.61 |
chr8_107292888_107294249 | 6.15 |
Nfat5 |
nuclear factor of activated T cells 5 |
9 |
0.98 |
chr14_55824498_55825973 | 6.14 |
Nfatc4 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
198 |
0.87 |
chr11_95990909_95991822 | 6.13 |
Igf2bp1 |
insulin-like growth factor 2 mRNA binding protein 1 |
8754 |
0.09 |
chr10_93731269_93731731 | 6.13 |
Gm15963 |
predicted gene 15963 |
3293 |
0.2 |
chr4_8689860_8690380 | 6.11 |
Chd7 |
chromodomain helicase DNA binding protein 7 |
286 |
0.93 |
chr4_138216258_138217700 | 6.07 |
Hp1bp3 |
heterochromatin protein 1, binding protein 3 |
148 |
0.91 |
chr10_40349107_40350122 | 6.07 |
Cdk19 |
cyclin-dependent kinase 19 |
88 |
0.86 |
chr10_120978150_120978739 | 6.06 |
Lemd3 |
LEM domain containing 3 |
888 |
0.49 |
chr3_144201827_144203140 | 6.05 |
Lmo4 |
LIM domain only 4 |
87 |
0.97 |
chr12_17725209_17725360 | 6.01 |
Hpcal1 |
hippocalcin-like 1 |
2942 |
0.31 |
chr1_106171607_106172350 | 6.01 |
Phlpp1 |
PH domain and leucine rich repeat protein phosphatase 1 |
226 |
0.72 |
chr15_102203424_102203965 | 5.99 |
Zfp740 |
zinc finger protein 740 |
3 |
0.49 |
chr11_60104775_60106860 | 5.94 |
Rai1 |
retinoic acid induced 1 |
640 |
0.67 |
chr7_100607194_100608447 | 5.94 |
Rab6a |
RAB6A, member RAS oncogene family |
130 |
0.55 |
chr15_100599610_100600576 | 5.89 |
Pou6f1 |
POU domain, class 6, transcription factor 1 |
109 |
0.48 |
chr9_115309763_115310685 | 5.89 |
Stt3b |
STT3, subunit of the oligosaccharyltransferase complex, homolog B (S. cerevisiae) |
197 |
0.94 |
chr4_133813137_133813697 | 5.86 |
Gm12974 |
predicted gene 12974 |
3003 |
0.18 |
chr12_51691136_51692207 | 5.85 |
Strn3 |
striatin, calmodulin binding protein 3 |
216 |
0.81 |
chr11_98795502_98796538 | 5.82 |
Msl1 |
male specific lethal 1 |
220 |
0.87 |
chr12_82168898_82169558 | 5.79 |
Sipa1l1 |
signal-induced proliferation-associated 1 like 1 |
92 |
0.54 |
chr4_133753861_133754198 | 5.77 |
Arid1a |
AT rich interactive domain 1A (SWI-like) |
47 |
0.97 |
chr18_21299601_21300892 | 5.76 |
Garem1 |
GRB2 associated regulator of MAPK1 subtype 1 |
108 |
0.96 |
chr4_141537813_141538641 | 5.73 |
Spen |
spen family transcription repressor |
26 |
0.97 |
chr2_52675982_52676813 | 5.72 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
185 |
0.96 |
chr12_69681373_69682134 | 5.70 |
Sos2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
88 |
0.97 |
chr9_103288630_103288787 | 5.68 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
411 |
0.82 |
chr1_59762633_59764016 | 5.68 |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
76 |
0.96 |
chr11_6444058_6445126 | 5.67 |
H2az2 |
H2A.Z histone variant 2 |
149 |
0.88 |
chr8_46739090_46739964 | 5.67 |
Gm16675 |
predicted gene, 16675 |
12 |
0.73 |
chr5_137786077_137787112 | 5.65 |
Mepce |
methylphosphate capping enzyme |
69 |
0.92 |
chr17_46857818_46858430 | 5.65 |
Bicral |
BRD4 interacting chromatin remodeling complex associated protein like |
358 |
0.84 |
chr16_94570319_94571250 | 5.63 |
Dyrk1a |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a |
80 |
0.97 |
chr6_127322214_127322412 | 5.62 |
Gm42458 |
predicted gene 42458 |
3544 |
0.15 |
chr6_137319744_137319895 | 5.62 |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
67354 |
0.12 |
chr17_32685870_32686141 | 5.57 |
Cyp4f15 |
cytochrome P450, family 4, subfamily f, polypeptide 15 |
326 |
0.81 |
chr11_87986817_87988025 | 5.57 |
Dynll2 |
dynein light chain LC8-type 2 |
65 |
0.96 |
chr6_124919273_124920636 | 5.54 |
Ptms |
parathymosin |
149 |
0.88 |
chr10_127288807_127289691 | 5.54 |
Mbd6 |
methyl-CpG binding domain protein 6 |
231 |
0.7 |
chr11_102316544_102317735 | 5.53 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
148 |
0.92 |
chr2_38286754_38287566 | 5.52 |
Dennd1a |
DENN/MADD domain containing 1A |
28 |
0.97 |
chr9_70678675_70679795 | 5.50 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
219 |
0.93 |
chr12_101028530_101029714 | 5.48 |
Ccdc88c |
coiled-coil domain containing 88C |
66 |
0.95 |
chrX_104200417_104201582 | 5.43 |
Nexmif |
neurite extension and migration factor |
118 |
0.97 |
chr11_107131631_107132030 | 5.40 |
Bptf |
bromodomain PHD finger transcription factor |
92 |
0.96 |
chrX_136135584_136135889 | 5.39 |
Bex4 |
brain expressed X-linked 4 |
3260 |
0.16 |
chr12_12941527_12942979 | 5.36 |
Mycn |
v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived |
339 |
0.83 |
chr5_115631746_115632284 | 5.35 |
Rab35 |
RAB35, member RAS oncogene family |
107 |
0.62 |
chr19_32227307_32227475 | 5.33 |
Sgms1 |
sphingomyelin synthase 1 |
11421 |
0.22 |
chr10_98914957_98915249 | 5.25 |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
49 |
0.99 |
chr17_15375662_15377138 | 5.25 |
Dll1 |
delta like canonical Notch ligand 1 |
424 |
0.8 |
chr4_33923766_33925291 | 5.23 |
Cnr1 |
cannabinoid receptor 1 (brain) |
65 |
0.98 |
chr17_39846240_39846403 | 5.23 |
CT010467.1 |
18s RNA, related sequence 5 |
32 |
0.97 |
chr2_168206505_168207218 | 5.23 |
Adnp |
activity-dependent neuroprotective protein |
61 |
0.95 |
chr19_41371598_41371749 | 5.22 |
Pik3ap1 |
phosphoinositide-3-kinase adaptor protein 1 |
13423 |
0.24 |
chr8_88199683_88200218 | 5.21 |
Tent4b |
terminal nucleotidyltransferase 4B |
736 |
0.61 |
chr6_83456116_83457458 | 5.20 |
Tet3 |
tet methylcytosine dioxygenase 3 |
395 |
0.77 |
chr2_34372048_34372447 | 5.19 |
Pbx3 |
pre B cell leukemia homeobox 3 |
203 |
0.94 |
chr11_106084123_106085101 | 5.18 |
Map3k3 |
mitogen-activated protein kinase kinase kinase 3 |
1 |
0.96 |
chr11_12036502_12038049 | 5.18 |
Grb10 |
growth factor receptor bound protein 10 |
126 |
0.97 |
chr7_44436787_44436938 | 5.17 |
Lrrc4b |
leucine rich repeat containing 4B |
5623 |
0.08 |
chr7_29292074_29292661 | 5.17 |
Ppp1r14a |
protein phosphatase 1, regulatory inhibitor subunit 14A |
3055 |
0.14 |
chr4_107801455_107802736 | 5.15 |
Lrp8os3 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor, opposite strand 3 |
31 |
0.53 |
chr11_29373288_29374224 | 5.15 |
Ccdc88a |
coiled coil domain containing 88A |
21 |
0.97 |
chr19_53329198_53330470 | 5.14 |
Mxi1 |
MAX interactor 1, dimerization protein |
26 |
0.97 |
chr5_118559568_118560229 | 5.05 |
Med13l |
mediator complex subunit 13-like |
781 |
0.58 |
chr3_35932298_35933364 | 5.04 |
Dcun1d1 |
DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae) |
5 |
0.73 |
chr2_51946774_51947120 | 5.04 |
Nmi |
N-myc (and STAT) interactor |
5630 |
0.18 |
chr3_108096355_108096541 | 5.02 |
Gnat2 |
guanine nucleotide binding protein, alpha transducing 2 |
795 |
0.42 |
chr14_115040506_115042372 | 4.99 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1440 |
0.19 |
chr17_35164786_35165560 | 4.96 |
Gm17705 |
predicted gene, 17705 |
54 |
0.72 |
chrX_93831605_93832731 | 4.94 |
Pdk3 |
pyruvate dehydrogenase kinase, isoenzyme 3 |
33 |
0.98 |
chr16_11270757_11270983 | 4.93 |
Mir1945 |
microRNA 1945 |
16425 |
0.12 |
chr1_152766000_152766716 | 4.92 |
Rgl1 |
ral guanine nucleotide dissociation stimulator,-like 1 |
7 |
0.7 |
chr15_83429499_83429672 | 4.92 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
3230 |
0.21 |
chr15_78928102_78928484 | 4.92 |
Lgals1 |
lectin, galactose binding, soluble 1 |
1567 |
0.18 |
chr14_49172432_49173089 | 4.91 |
Naa30 |
N(alpha)-acetyltransferase 30, NatC catalytic subunit |
162 |
0.95 |
chr2_84682372_84682528 | 4.91 |
Med19 |
mediator complex subunit 19 |
3183 |
0.1 |
chr11_103132227_103133103 | 4.90 |
Hexim2 |
hexamethylene bis-acetamide inducible 2 |
236 |
0.88 |
chr10_117025940_117026091 | 4.89 |
Gm10747 |
predicted gene 10747 |
17731 |
0.11 |
chr16_56075244_56076135 | 4.89 |
Senp7 |
SUMO1/sentrin specific peptidase 7 |
209 |
0.9 |
chr14_21499744_21500378 | 4.88 |
Kat6b |
K(lysine) acetyltransferase 6B |
207 |
0.95 |
chr12_84996515_84997164 | 4.88 |
Ylpm1 |
YLP motif containing 1 |
349 |
0.83 |
chr11_86357245_86357827 | 4.88 |
Med13 |
mediator complex subunit 13 |
66 |
0.98 |
chr7_132774033_132774186 | 4.87 |
Fam53b |
family with sequence similarity 53, member B |
2807 |
0.27 |
chr5_43232754_43234178 | 4.87 |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
296 |
0.85 |
chr15_99126338_99127196 | 4.86 |
Spats2 |
spermatogenesis associated, serine-rich 2 |
27 |
0.95 |
chr6_72898945_72900607 | 4.86 |
Kcmf1 |
potassium channel modulatory factor 1 |
73 |
0.97 |
chr9_65554974_65555491 | 4.85 |
Plekho2 |
pleckstrin homology domain containing, family O member 2 |
6932 |
0.14 |
chr16_96918754_96918917 | 4.84 |
Gm32432 |
predicted gene, 32432 |
78 |
0.99 |
chr13_91460972_91461704 | 4.83 |
Ssbp2 |
single-stranded DNA binding protein 2 |
157 |
0.97 |
chr11_51999751_52000565 | 4.82 |
Ube2b |
ubiquitin-conjugating enzyme E2B |
321 |
0.69 |
chr2_165884402_165885933 | 4.81 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr14_56811190_56811879 | 4.78 |
Zmym5 |
zinc finger, MYM-type 5 |
70 |
0.85 |
chr15_36793516_36794080 | 4.78 |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
39 |
0.97 |
chr5_57715202_57716235 | 4.76 |
4932441J04Rik |
RIKEN cDNA 4932441J04 gene |
2202 |
0.2 |
chr2_153560652_153561518 | 4.76 |
Nol4l |
nucleolar protein 4-like |
31114 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 17.8 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
5.5 | 16.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
5.1 | 15.4 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
4.9 | 4.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
4.8 | 14.5 | GO:0036166 | phenotypic switching(GO:0036166) |
4.1 | 12.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
4.0 | 12.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
3.9 | 11.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
3.8 | 11.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
3.7 | 15.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
3.3 | 13.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
3.2 | 9.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.7 | 16.5 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
2.7 | 10.9 | GO:0007296 | vitellogenesis(GO:0007296) |
2.7 | 13.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
2.7 | 10.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
2.6 | 10.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
2.5 | 7.6 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
2.5 | 7.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
2.5 | 19.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
2.4 | 4.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.4 | 7.1 | GO:0036394 | amylase secretion(GO:0036394) |
2.3 | 6.9 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
2.3 | 9.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
2.3 | 4.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
2.2 | 4.4 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.2 | 13.0 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
2.2 | 8.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.2 | 10.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
2.1 | 6.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.1 | 10.7 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
2.1 | 8.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
2.1 | 16.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
2.1 | 6.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
2.1 | 18.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
2.0 | 6.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
2.0 | 7.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
2.0 | 5.9 | GO:0061010 | gall bladder development(GO:0061010) |
1.9 | 5.8 | GO:0000087 | mitotic M phase(GO:0000087) |
1.9 | 1.9 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.8 | 7.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.8 | 12.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.8 | 7.1 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
1.8 | 5.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.7 | 5.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.7 | 5.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.7 | 6.8 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.7 | 6.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.7 | 6.7 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.7 | 5.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.7 | 5.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
1.6 | 4.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.6 | 16.0 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.6 | 16.0 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
1.6 | 12.7 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.6 | 3.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.6 | 7.9 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.6 | 4.7 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.6 | 6.3 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
1.5 | 6.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.5 | 4.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.5 | 4.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.5 | 6.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.5 | 6.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
1.5 | 6.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.5 | 4.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.5 | 7.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.5 | 5.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.4 | 5.7 | GO:0008228 | opsonization(GO:0008228) |
1.4 | 28.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
1.4 | 2.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.4 | 7.1 | GO:0070836 | caveola assembly(GO:0070836) |
1.4 | 8.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.4 | 5.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.4 | 8.3 | GO:0015871 | choline transport(GO:0015871) |
1.4 | 13.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.4 | 4.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.4 | 6.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.4 | 4.1 | GO:0080009 | mRNA methylation(GO:0080009) |
1.4 | 4.1 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.3 | 8.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.3 | 4.0 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.3 | 8.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.3 | 4.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.3 | 4.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.3 | 7.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.3 | 3.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.3 | 6.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.3 | 5.2 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
1.3 | 3.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.3 | 3.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.3 | 1.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.3 | 3.8 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.3 | 1.3 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
1.3 | 6.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.2 | 3.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.2 | 5.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.2 | 4.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.2 | 1.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
1.2 | 1.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.2 | 3.7 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.2 | 3.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.2 | 4.9 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.2 | 6.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.2 | 1.2 | GO:0045632 | negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
1.2 | 3.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.2 | 2.4 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.2 | 3.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.2 | 3.6 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.2 | 4.8 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
1.2 | 3.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.2 | 4.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.2 | 3.5 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
1.2 | 3.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.2 | 5.8 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
1.2 | 2.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.2 | 3.5 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.2 | 3.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.1 | 2.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.1 | 1.1 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.1 | 6.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.1 | 2.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.1 | 1.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.1 | 6.8 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.1 | 3.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.1 | 3.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.1 | 3.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.1 | 2.2 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
1.1 | 3.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.1 | 3.3 | GO:0015817 | histidine transport(GO:0015817) |
1.1 | 2.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.1 | 1.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.1 | 3.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.1 | 1.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.1 | 4.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.0 | 1.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
1.0 | 4.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.0 | 5.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
1.0 | 2.1 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
1.0 | 3.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.0 | 7.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.0 | 5.1 | GO:0097459 | iron ion import into cell(GO:0097459) |
1.0 | 2.0 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.0 | 5.0 | GO:0036302 | atrioventricular canal development(GO:0036302) |
1.0 | 7.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.0 | 3.0 | GO:0042938 | dipeptide transport(GO:0042938) |
1.0 | 8.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
1.0 | 3.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.0 | 2.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.0 | 1.0 | GO:0034728 | nucleosome organization(GO:0034728) |
1.0 | 3.0 | GO:0090148 | membrane fission(GO:0090148) |
1.0 | 2.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.0 | 2.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.0 | 6.8 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.0 | 2.9 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.0 | 6.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.0 | 1.0 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
1.0 | 2.9 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
1.0 | 1.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.0 | 1.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) COPII-coated vesicle budding(GO:0090114) |
1.0 | 2.9 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.0 | 4.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.0 | 6.7 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
1.0 | 4.8 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.9 | 1.9 | GO:0035973 | aggrephagy(GO:0035973) |
0.9 | 3.8 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.9 | 5.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.9 | 3.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.9 | 0.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.9 | 0.9 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.9 | 7.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.9 | 1.8 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.9 | 8.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.9 | 5.5 | GO:0050779 | RNA destabilization(GO:0050779) |
0.9 | 3.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.9 | 4.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.9 | 2.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.9 | 4.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.9 | 3.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.9 | 3.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.9 | 2.7 | GO:0050904 | diapedesis(GO:0050904) |
0.9 | 2.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.9 | 0.9 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.9 | 1.8 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.9 | 6.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.9 | 0.9 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.9 | 2.6 | GO:0008050 | female courtship behavior(GO:0008050) |
0.9 | 3.5 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.9 | 3.5 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.9 | 3.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.9 | 2.6 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.9 | 2.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.9 | 2.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 8.6 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.9 | 2.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 5.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.8 | 1.7 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.8 | 2.5 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.8 | 3.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.8 | 5.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.8 | 0.8 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.8 | 3.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.8 | 0.8 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.8 | 2.5 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.8 | 2.5 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.8 | 2.5 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.8 | 9.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.8 | 9.8 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.8 | 11.4 | GO:0043486 | histone exchange(GO:0043486) |
0.8 | 4.9 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.8 | 2.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.8 | 1.6 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.8 | 7.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.8 | 8.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.8 | 3.2 | GO:0009597 | detection of virus(GO:0009597) |
0.8 | 2.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.8 | 3.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.8 | 4.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.8 | 1.5 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.8 | 4.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.8 | 2.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.8 | 3.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.8 | 5.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.8 | 2.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.8 | 1.5 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.8 | 3.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.8 | 2.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.8 | 2.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.8 | 2.3 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.8 | 5.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.8 | 1.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.8 | 3.0 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.7 | 3.0 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.7 | 2.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.7 | 3.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.7 | 3.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.7 | 4.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.7 | 1.5 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.7 | 6.6 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.7 | 8.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.7 | 4.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.7 | 3.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.7 | 2.9 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.7 | 4.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.7 | 2.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.7 | 4.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.7 | 1.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.7 | 0.7 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.7 | 2.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.7 | 1.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.7 | 3.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.7 | 0.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.7 | 2.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.7 | 2.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.7 | 4.3 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.7 | 1.4 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.7 | 2.1 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.7 | 4.2 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.7 | 0.7 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.7 | 4.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.7 | 0.7 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.7 | 4.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.7 | 3.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.7 | 32.4 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.7 | 1.4 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.7 | 3.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.7 | 8.9 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.7 | 1.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.7 | 1.4 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.7 | 1.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.7 | 1.4 | GO:0032439 | endosome localization(GO:0032439) |
0.7 | 4.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.7 | 1.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.7 | 4.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.7 | 0.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.7 | 3.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.7 | 1.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.7 | 3.4 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.7 | 0.7 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.7 | 3.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 2.0 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.7 | 4.0 | GO:1901563 | response to camptothecin(GO:1901563) |
0.7 | 1.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.7 | 2.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.7 | 0.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.7 | 2.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.7 | 0.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.7 | 0.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.7 | 2.6 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.7 | 0.7 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.7 | 7.2 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.6 | 1.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.6 | 3.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.6 | 1.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 1.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.6 | 9.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.6 | 6.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.6 | 4.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 1.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 6.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.6 | 1.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.6 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 1.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.6 | 1.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.6 | 2.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.6 | 18.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.6 | 4.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.6 | 1.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.6 | 1.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.6 | 0.6 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.6 | 6.0 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.6 | 1.2 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.6 | 4.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.6 | 5.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.6 | 5.9 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.6 | 1.8 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 1.2 | GO:0043366 | beta selection(GO:0043366) |
0.6 | 1.7 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.6 | 1.2 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.6 | 1.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.6 | 0.6 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.6 | 1.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.6 | 0.6 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.6 | 1.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 4.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.6 | 1.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.6 | 2.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.6 | 2.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.6 | 2.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.6 | 2.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 2.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.6 | 1.7 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.6 | 3.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.6 | 1.7 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.6 | 0.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.6 | 5.0 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.6 | 2.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.6 | 1.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.6 | 1.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 3.8 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 2.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.5 | 1.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.5 | 4.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.5 | 3.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.5 | 0.5 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.5 | 1.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.5 | 4.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.5 | 1.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.5 | 1.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 1.6 | GO:0001555 | oocyte growth(GO:0001555) |
0.5 | 2.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 1.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 | 3.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.5 | 6.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.5 | 1.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 2.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 5.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.5 | 9.0 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.5 | 1.6 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.5 | 0.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.5 | 7.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 5.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.5 | 1.6 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.5 | 3.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.5 | 1.0 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.5 | 2.1 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
0.5 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 1.6 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.5 | 2.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.5 | 3.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 2.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 2.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.5 | 2.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 4.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.5 | 1.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.5 | 15.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.5 | 5.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.5 | 0.5 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.5 | 6.6 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.5 | 2.0 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.5 | 17.6 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.5 | 3.0 | GO:0051639 | actin filament network formation(GO:0051639) |
0.5 | 1.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 1.5 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.5 | 3.0 | GO:1901660 | calcium ion export(GO:1901660) |
0.5 | 8.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.5 | 1.0 | GO:0030578 | PML body organization(GO:0030578) |
0.5 | 2.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.5 | 2.5 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.5 | 4.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.5 | 1.5 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.5 | 1.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.5 | 2.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 1.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.5 | 0.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.5 | 1.0 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.5 | 3.4 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.5 | 1.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.5 | 1.5 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.5 | 2.0 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 1.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.5 | 14.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.5 | 1.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.5 | 1.5 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.5 | 2.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.5 | 1.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.5 | 9.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.5 | 1.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.5 | 0.5 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.5 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 2.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.5 | 0.5 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.5 | 1.4 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.5 | 1.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 1.9 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.5 | 0.5 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.5 | 5.1 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.5 | 0.9 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.5 | 0.9 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.5 | 2.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.5 | 0.9 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.5 | 3.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.5 | 0.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 3.7 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.5 | 0.9 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.5 | 0.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.5 | 1.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.5 | 6.8 | GO:0016925 | protein sumoylation(GO:0016925) |
0.5 | 1.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 1.8 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.5 | 4.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 1.8 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.4 | 1.3 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.4 | 0.9 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.4 | 3.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.4 | 0.9 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.4 | 1.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 1.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.4 | 0.4 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.4 | 0.4 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.4 | 1.7 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.4 | 1.7 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.4 | 1.7 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 2.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.4 | 3.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 3.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.4 | 1.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 3.4 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.4 | 2.1 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.4 | 1.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.4 | 1.7 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.4 | 6.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 0.9 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.4 | 0.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 2.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.4 | 1.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 2.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.4 | 2.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.4 | 12.6 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.4 | 0.8 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.4 | 1.2 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.4 | 1.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 0.4 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.4 | 1.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.4 | 1.7 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.4 | 2.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 5.8 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.4 | 0.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.4 | 0.8 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.4 | 1.6 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.4 | 1.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 1.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.4 | 6.1 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.4 | 1.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 1.6 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.4 | 0.4 | GO:0045472 | response to ether(GO:0045472) |
0.4 | 2.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.4 | 1.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.4 | 2.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.4 | 3.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.4 | 2.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.4 | 2.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.4 | 2.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 0.8 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.4 | 2.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 0.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 0.4 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.4 | 5.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.4 | 1.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 | 3.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 7.1 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.4 | 0.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 2.0 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.4 | 2.0 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.4 | 0.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.4 | 2.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 1.6 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.4 | 1.2 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.4 | 0.8 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.4 | 9.9 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.4 | 2.7 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.4 | 0.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.4 | 0.8 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.4 | 2.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 3.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.4 | 0.4 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.4 | 3.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 7.9 | GO:0021591 | ventricular system development(GO:0021591) |
0.4 | 3.0 | GO:0031297 | replication fork processing(GO:0031297) |
0.4 | 1.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.4 | 0.4 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.4 | 1.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.4 | 0.4 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.4 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.4 | 0.4 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.4 | 0.4 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.4 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 0.7 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.4 | 0.7 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.4 | 2.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 1.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 0.7 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.4 | 6.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 1.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 0.7 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.4 | 1.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 1.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 1.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 8.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 1.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.4 | 1.1 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 1.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.3 | 1.4 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.3 | 9.0 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 1.4 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 2.8 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.3 | 1.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 3.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 1.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 1.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 1.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 1.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.3 | 0.7 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.3 | 2.0 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 1.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 0.7 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.3 | 2.0 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.3 | 0.3 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.3 | 1.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 0.7 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.3 | 0.3 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.3 | 1.0 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 1.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 1.3 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.3 | 0.7 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 0.7 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.3 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 1.3 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.3 | 1.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 1.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 0.3 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.3 | 8.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 1.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 1.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 0.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 3.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 0.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.3 | 1.3 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.3 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 5.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 1.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 1.9 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 0.6 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 0.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 3.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.3 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 0.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.3 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 0.9 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 0.6 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.3 | 2.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 0.6 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 1.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 2.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 2.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 0.3 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.3 | 0.9 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.3 | 2.7 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 1.8 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.3 | 0.9 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 0.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.3 | 0.6 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 2.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 2.7 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.3 | 0.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.3 | 0.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 0.3 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.3 | 1.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 1.8 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 1.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.3 | 2.6 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.3 | 1.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 1.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 3.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 2.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 1.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 1.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 1.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 1.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 0.6 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 0.3 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.3 | 0.6 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 0.3 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.3 | 1.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 0.8 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 0.8 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) |
0.3 | 1.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.3 | 0.3 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 1.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 1.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.3 | 3.8 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 0.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.3 | 4.1 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.3 | 14.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.3 | 2.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 1.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 1.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 1.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.3 | 0.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 5.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 0.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 1.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 0.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.3 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 7.4 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.3 | 0.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 1.0 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 1.6 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 2.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.3 | 0.3 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.3 | 0.8 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 0.3 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
0.3 | 1.0 | GO:0042168 | heme metabolic process(GO:0042168) |
0.3 | 0.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 0.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 0.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 0.8 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.3 | 0.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.3 | 1.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 1.3 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 1.3 | GO:1904293 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) negative regulation of ERAD pathway(GO:1904293) |
0.3 | 0.8 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 3.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 0.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 1.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 1.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 1.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.2 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.2 | 2.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 1.5 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 1.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 1.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 2.9 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.5 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.2 | 2.2 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.2 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 2.9 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.2 | 0.2 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.2 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 1.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.2 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.2 | 0.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 0.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.5 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 1.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.2 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.2 | 1.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 1.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 1.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 0.9 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.2 | 1.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 1.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 2.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 5.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 1.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 2.3 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.2 | 1.4 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.5 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.2 | 1.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 2.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 3.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 2.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 8.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 0.9 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.7 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 0.7 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.2 | 0.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 1.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 2.3 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.2 | 4.3 | GO:0098930 | axonal transport(GO:0098930) |
0.2 | 0.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 0.7 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 0.7 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 1.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 1.8 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 1.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.2 | 0.2 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.2 | 0.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.2 | 3.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 1.6 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.2 | 3.6 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.2 | 0.9 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 3.3 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 3.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.2 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.2 | 1.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 0.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 4.6 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.2 | 0.2 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 0.2 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) |
0.2 | 0.7 | GO:0009838 | abscission(GO:0009838) |
0.2 | 1.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 1.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.9 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 0.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.9 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 2.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 7.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 1.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.4 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.2 | 0.8 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 0.6 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.2 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.2 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.2 | 0.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 0.2 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.2 | 0.2 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.2 | 0.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 3.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 2.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 0.8 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.2 | 1.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 1.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 1.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.4 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.2 | 1.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 2.6 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.2 | 3.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 1.6 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 1.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 1.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 2.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 4.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.2 | 0.4 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 0.4 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 2.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 1.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 4.8 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.2 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 1.3 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.2 | 1.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 1.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.6 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.2 | 0.2 | GO:0009750 | response to fructose(GO:0009750) |
0.2 | 0.2 | GO:0044026 | maintenance of DNA methylation(GO:0010216) DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.2 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 2.3 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.2 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.2 | 4.1 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 2.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 4.3 | GO:0006413 | translational initiation(GO:0006413) |
0.2 | 1.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 0.9 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 3.7 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.2 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 4.4 | GO:0098840 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.2 | 1.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 3.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.5 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.9 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.2 | 4.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.2 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.2 | 0.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 0.2 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.2 | 1.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.5 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 0.9 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.2 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 1.6 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.2 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.2 | GO:0033047 | regulation of mitotic sister chromatid separation(GO:0010965) regulation of mitotic sister chromatid segregation(GO:0033047) positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.2 | 0.4 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 0.5 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.2 | 4.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.2 | 0.4 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.2 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 1.9 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.2 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.9 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.2 | 1.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 1.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 1.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.2 | 0.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.3 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
0.2 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.5 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 0.5 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.2 | 0.3 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 0.3 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.3 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.2 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 3.3 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.2 | 0.3 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.2 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 7.6 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 1.3 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 0.5 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 1.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 0.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 8.7 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 1.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.2 | 0.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 5.4 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.2 | 0.6 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.2 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) negative regulation of oxidative phosphorylation(GO:0090324) |
0.2 | 0.2 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.2 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 0.6 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.2 | 0.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 1.7 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.2 | 8.4 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 0.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.3 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.2 | 1.8 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.1 | 1.5 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 1.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 1.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.4 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.1 | 0.1 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.1 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.9 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.9 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.8 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.4 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.4 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 1.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 1.0 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 1.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.6 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.1 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 14.2 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.1 | 1.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.8 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 1.0 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.1 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.1 | 0.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.1 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 1.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 1.4 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 2.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.1 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.9 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 1.5 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.8 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.1 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 2.8 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 2.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.1 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.1 | 0.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.3 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 0.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.7 | GO:0007595 | lactation(GO:0007595) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 1.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.5 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.5 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 1.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 1.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.5 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 1.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.4 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.5 | GO:0051231 | spindle elongation(GO:0051231) |
0.1 | 2.1 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.1 | 0.2 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 0.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 9.9 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.7 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 1.0 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.1 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.1 | 0.6 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 3.7 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 1.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.2 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 1.1 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.1 | 0.2 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 1.0 | GO:1903205 | regulation of hydrogen peroxide-induced cell death(GO:1903205) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.1 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.3 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 1.7 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 1.4 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 1.2 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.1 | GO:0071025 | RNA surveillance(GO:0071025) |
0.1 | 0.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 1.6 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 1.2 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.2 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.3 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.1 | 0.1 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.1 | 1.4 | GO:0043534 | blood vessel endothelial cell migration(GO:0043534) |
0.1 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 1.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.6 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.6 | GO:0018205 | peptidyl-lysine modification(GO:0018205) |
0.1 | 1.0 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.3 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.7 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.1 | 0.1 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 1.2 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.1 | 0.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.4 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.8 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.4 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.3 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 1.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.2 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.2 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 1.4 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.2 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 1.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 1.1 | GO:0051591 | response to cAMP(GO:0051591) |
0.1 | 0.2 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.5 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.6 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.5 | GO:0051904 | pigment granule transport(GO:0051904) |
0.1 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.5 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.1 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.4 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.1 | GO:0042511 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.6 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.4 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 0.1 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.6 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.9 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.1 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.4 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.1 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.1 | 0.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 0.6 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 1.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.7 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.1 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 0.1 | GO:0046112 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) nucleobase biosynthetic process(GO:0046112) |
0.1 | 0.6 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.1 | 0.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.2 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.1 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.1 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.3 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.1 | GO:0048308 | organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) |
0.1 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.1 | GO:0051645 | Golgi localization(GO:0051645) |
0.1 | 0.6 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 1.2 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.1 | GO:0019433 | positive regulation of triglyceride catabolic process(GO:0010898) triglyceride catabolic process(GO:0019433) |
0.1 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.2 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.2 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.2 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.4 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.1 | 0.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 1.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.1 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.1 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.8 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.8 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.1 | 0.3 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.4 | GO:0046148 | pigment biosynthetic process(GO:0046148) |
0.1 | 0.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.7 | GO:0033044 | regulation of chromosome organization(GO:0033044) |
0.1 | 0.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.3 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.1 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.0 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.4 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.1 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.3 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.0 | 0.8 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 1.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.0 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.0 | 0.3 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.4 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 3.0 | GO:0032259 | methylation(GO:0032259) |
0.0 | 0.0 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.0 | GO:0002716 | negative regulation of natural killer cell mediated immunity(GO:0002716) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 1.3 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
0.0 | 1.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.1 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.0 | 0.0 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.0 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.7 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.1 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.0 | 0.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.2 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 0.0 | GO:0002714 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.0 | 0.1 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
0.0 | 0.1 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.0 | 0.1 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) |
0.0 | 1.8 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.0 | GO:0042092 | type 2 immune response(GO:0042092) |
0.0 | 0.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.1 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.0 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.0 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.3 | GO:2000107 | negative regulation of leukocyte apoptotic process(GO:2000107) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.0 | 0.0 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:1902884 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of response to oxidative stress(GO:1902884) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 5.6 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.0 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.0 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.0 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.0 | 0.1 | GO:0071514 | genetic imprinting(GO:0071514) |
0.0 | 0.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.0 | 0.0 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.1 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.0 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.1 | GO:1905037 | autophagosome organization(GO:1905037) |
0.0 | 0.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.0 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.0 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.0 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.0 | 0.3 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.0 | GO:0006473 | protein acetylation(GO:0006473) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.4 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.0 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.0 | 0.0 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.0 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.0 | 0.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.0 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.0 | GO:0051875 | pigment granule localization(GO:0051875) |
0.0 | 0.0 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.0 | 0.0 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.0 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.0 | 0.0 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.0 | GO:2000054 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 15.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.2 | 8.7 | GO:0005955 | calcineurin complex(GO:0005955) |
2.1 | 8.3 | GO:0072487 | MSL complex(GO:0072487) |
2.1 | 8.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.0 | 14.3 | GO:0042382 | paraspeckles(GO:0042382) |
2.0 | 8.0 | GO:0005642 | annulate lamellae(GO:0005642) |
2.0 | 11.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.9 | 5.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.8 | 5.4 | GO:0031417 | NatC complex(GO:0031417) |
1.7 | 13.8 | GO:0001650 | fibrillar center(GO:0001650) |
1.7 | 5.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.7 | 8.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.6 | 6.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.5 | 9.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.5 | 7.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.4 | 31.5 | GO:0090544 | BAF-type complex(GO:0090544) |
1.4 | 11.2 | GO:0030056 | hemidesmosome(GO:0030056) |
1.4 | 54.8 | GO:0031519 | PcG protein complex(GO:0031519) |
1.3 | 9.4 | GO:0001939 | female pronucleus(GO:0001939) |
1.3 | 2.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.3 | 6.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.3 | 3.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.2 | 5.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.2 | 21.1 | GO:0010369 | chromocenter(GO:0010369) |
1.2 | 10.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.2 | 5.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.1 | 17.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.1 | 10.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.1 | 7.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.1 | 4.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.1 | 3.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
1.1 | 5.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.1 | 57.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.1 | 6.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.0 | 5.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.0 | 14.5 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
1.0 | 4.1 | GO:0000938 | GARP complex(GO:0000938) |
1.0 | 3.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.0 | 20.5 | GO:0000786 | nucleosome(GO:0000786) |
1.0 | 3.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.9 | 5.6 | GO:1990462 | omegasome(GO:1990462) |
0.9 | 3.7 | GO:0042825 | TAP complex(GO:0042825) |
0.9 | 0.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.9 | 21.6 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.9 | 5.3 | GO:0031415 | NatA complex(GO:0031415) |
0.9 | 25.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.9 | 6.8 | GO:0097470 | ribbon synapse(GO:0097470) |
0.8 | 16.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.8 | 2.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.8 | 3.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.8 | 2.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.8 | 3.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.8 | 26.6 | GO:0016592 | mediator complex(GO:0016592) |
0.7 | 3.0 | GO:0030689 | Noc complex(GO:0030689) |
0.7 | 5.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.7 | 11.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.7 | 8.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.7 | 2.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.7 | 7.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.7 | 2.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.7 | 2.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 27.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.7 | 4.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.7 | 3.4 | GO:0033503 | HULC complex(GO:0033503) |
0.7 | 2.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 5.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.7 | 3.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.7 | 2.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.7 | 2.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.6 | 4.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 5.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.6 | 9.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.6 | 1.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.6 | 3.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.6 | 15.1 | GO:0030894 | replisome(GO:0030894) |
0.6 | 1.8 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.6 | 1.8 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 2.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.6 | 19.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.6 | 1.8 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 2.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.6 | 4.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.6 | 2.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 2.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 3.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.5 | 7.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 1.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.5 | 1.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.5 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 2.1 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.5 | 1.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.5 | 2.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 1.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.5 | 2.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 2.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.5 | 1.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 1.5 | GO:0030891 | VCB complex(GO:0030891) |
0.5 | 7.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.5 | 3.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.5 | 5.5 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 3.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.5 | 1.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 2.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.5 | 12.3 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.5 | 15.2 | GO:0005776 | autophagosome(GO:0005776) |
0.5 | 4.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.5 | 8.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.5 | 2.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.5 | 4.3 | GO:0032797 | SMN complex(GO:0032797) |
0.5 | 1.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 1.4 | GO:0005745 | m-AAA complex(GO:0005745) |
0.5 | 1.4 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.5 | 8.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 1.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.5 | 0.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.5 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 1.9 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 1.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.5 | 2.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.5 | 3.7 | GO:0000243 | commitment complex(GO:0000243) |
0.5 | 4.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 1.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 1.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.4 | 23.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 5.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.4 | 0.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.4 | 3.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 2.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.4 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 3.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 4.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 3.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 81.0 | GO:0000785 | chromatin(GO:0000785) |
0.4 | 14.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 1.2 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) XPC complex(GO:0071942) |
0.4 | 0.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 5.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 5.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 1.2 | GO:0000811 | GINS complex(GO:0000811) |
0.4 | 2.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.4 | 0.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 4.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.4 | 1.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 13.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 0.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 0.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 1.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.4 | 1.9 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 2.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 1.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 1.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 1.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 1.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 1.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 1.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 2.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 1.7 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 5.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 2.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 1.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 2.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 46.5 | GO:0016604 | nuclear body(GO:0016604) |
0.3 | 1.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 2.6 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 7.0 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 1.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 1.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.3 | 1.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 13.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 1.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 0.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 30.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 0.6 | GO:0005687 | U4 snRNP(GO:0005687) |
0.3 | 1.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 0.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 0.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 3.9 | GO:0005844 | polysome(GO:0005844) |
0.3 | 0.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 0.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 10.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 0.6 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.3 | 1.2 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 2.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 1.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 1.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 7.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.3 | 5.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 0.8 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 1.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 1.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 4.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 1.4 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 1.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 3.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.3 | 1.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 3.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 0.8 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 13.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 4.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.3 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 1.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 1.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 277.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 3.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 2.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 15.3 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 2.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 4.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 1.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 2.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 1.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 0.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.7 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 3.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 3.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 1.5 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.2 | 0.6 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 3.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 1.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 2.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 1.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 1.6 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 1.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 33.8 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 2.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 3.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 1.0 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 0.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 8.8 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.7 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 7.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 2.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 3.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 20.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 1.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 2.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 3.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 3.3 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 9.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 4.6 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.2 | 2.0 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 2.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 1.6 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.8 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 3.8 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 1.0 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 1.9 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 4.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.5 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.1 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 1.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 3.5 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.6 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 3.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 3.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 5.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 2.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 1.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.2 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 4.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.5 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 17.5 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 6.0 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 6.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 1.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 16.5 | GO:0031981 | nuclear lumen(GO:0031981) |
0.1 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 52.5 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 1.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 1.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.0 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0098573 | integral component of mitochondrial membrane(GO:0032592) intrinsic component of mitochondrial membrane(GO:0098573) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 1.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 1.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.1 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.0 | 5.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.0 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 1.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.8 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 1.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 30.0 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.8 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
3.9 | 15.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
3.0 | 17.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.8 | 2.8 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
2.7 | 8.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.7 | 8.0 | GO:0005119 | smoothened binding(GO:0005119) |
2.4 | 9.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.3 | 20.7 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
2.2 | 4.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
2.1 | 8.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.1 | 8.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
2.0 | 12.1 | GO:0043910 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
1.9 | 7.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.9 | 5.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.8 | 5.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.8 | 5.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.8 | 5.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.8 | 5.3 | GO:1990188 | euchromatin binding(GO:1990188) |
1.8 | 14.0 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
1.7 | 5.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
1.7 | 5.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.7 | 6.7 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.6 | 6.6 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.6 | 4.9 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.6 | 9.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.6 | 8.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.6 | 12.9 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.6 | 1.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.5 | 18.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.4 | 2.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.3 | 5.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.3 | 4.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.3 | 5.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.3 | 3.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.3 | 11.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.3 | 5.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.3 | 6.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.2 | 3.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.2 | 9.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.2 | 1.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.2 | 3.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.2 | 4.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.2 | 4.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.2 | 1.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.1 | 1.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.1 | 3.4 | GO:0019002 | GMP binding(GO:0019002) |
1.1 | 6.8 | GO:0000182 | rDNA binding(GO:0000182) |
1.1 | 9.0 | GO:0034046 | poly(G) binding(GO:0034046) |
1.1 | 4.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.1 | 3.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.1 | 3.3 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
1.1 | 3.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.1 | 16.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.1 | 3.2 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.1 | 5.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.1 | 24.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.0 | 7.3 | GO:0036122 | BMP binding(GO:0036122) |
1.0 | 6.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.0 | 5.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.0 | 3.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.0 | 10.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.0 | 4.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.0 | 4.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.0 | 5.0 | GO:0030274 | LIM domain binding(GO:0030274) |
1.0 | 12.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.0 | 31.7 | GO:0031491 | nucleosome binding(GO:0031491) |
1.0 | 1.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.0 | 3.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.0 | 2.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.0 | 2.9 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.9 | 5.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.9 | 6.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.9 | 3.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.9 | 0.9 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.9 | 10.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.9 | 4.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.9 | 2.7 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.9 | 1.8 | GO:0048030 | disaccharide binding(GO:0048030) |
0.9 | 2.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.9 | 1.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.9 | 7.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.9 | 6.1 | GO:0046790 | virion binding(GO:0046790) |
0.9 | 2.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.9 | 13.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.9 | 4.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.9 | 13.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.8 | 9.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.8 | 2.5 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.8 | 2.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.8 | 4.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.8 | 8.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.8 | 15.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.8 | 1.6 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.8 | 0.8 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.8 | 3.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.8 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.8 | 1.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.8 | 3.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.8 | 22.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.8 | 18.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.8 | 2.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.8 | 3.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.7 | 8.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.7 | 6.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.7 | 19.0 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.7 | 5.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.7 | 1.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.7 | 2.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.7 | 5.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.7 | 0.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.7 | 8.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 2.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.7 | 7.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.7 | 6.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.7 | 20.3 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.7 | 0.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.7 | 1.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 0.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.7 | 11.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.7 | 2.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.7 | 26.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.7 | 4.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.7 | 8.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 2.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.6 | 11.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.6 | 2.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.6 | 13.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 0.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.6 | 1.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.6 | 2.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.6 | 3.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.6 | 2.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.6 | 1.9 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.6 | 7.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 1.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.6 | 1.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.6 | 4.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.6 | 12.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.6 | 2.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 3.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 16.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.6 | 0.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.6 | 3.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 7.7 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.6 | 1.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.6 | 5.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 1.8 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.6 | 5.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.6 | 0.6 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.6 | 1.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.6 | 4.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 3.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.6 | 2.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.6 | 12.0 | GO:0035326 | enhancer binding(GO:0035326) |
0.6 | 35.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.6 | 1.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.6 | 2.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 25.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.6 | 3.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.6 | 1.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.6 | 1.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.6 | 0.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.6 | 1.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.6 | 5.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.6 | 2.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.5 | 1.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 4.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.5 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 1.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.5 | 27.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.5 | 2.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.5 | 2.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 10.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.5 | 2.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.5 | 3.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.5 | 1.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 16.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.5 | 2.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.5 | 3.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.5 | 1.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 14.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 6.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.5 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.5 | 6.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.5 | 4.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 1.0 | GO:0035877 | death effector domain binding(GO:0035877) |
0.5 | 2.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.5 | 2.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.5 | 4.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 1.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.5 | 2.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 1.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 5.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 7.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.5 | 4.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.5 | 1.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.5 | 1.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.5 | 1.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 1.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.5 | 1.9 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 1.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.5 | 2.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.5 | 1.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.5 | 10.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.5 | 1.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 30.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.5 | 1.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 1.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 12.1 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.5 | 0.9 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.5 | 6.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 2.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 5.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.5 | 9.5 | GO:0045502 | dynein binding(GO:0045502) |
0.5 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.5 | 3.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 1.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.4 | 1.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.4 | 0.9 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 3.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 5.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.4 | 0.4 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.4 | 0.9 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.4 | 3.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 1.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 0.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.4 | 0.4 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 0.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.4 | 1.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.4 | 1.7 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.4 | 1.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.4 | 8.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 1.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 1.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.4 | 5.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 2.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 5.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 0.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.4 | 0.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 2.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 2.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 3.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 2.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 3.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 2.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 1.2 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 5.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.4 | 1.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 1.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.4 | 1.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.4 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 45.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.4 | 1.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 0.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.4 | 0.8 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.4 | 29.2 | GO:0042393 | histone binding(GO:0042393) |
0.4 | 1.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.4 | 1.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 1.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 1.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.4 | 1.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 5.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.4 | 6.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.4 | 2.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 7.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 1.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 6.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.4 | 1.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 2.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.4 | 2.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 3.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 10.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 1.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 1.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 3.8 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 5.2 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
0.3 | 2.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.3 | 14.8 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.3 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 9.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 1.0 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 10.0 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.3 | 2.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 10.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.3 | 7.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 1.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 1.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 0.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 1.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 1.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 8.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 1.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 0.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.3 | 1.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 8.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.3 | 0.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 2.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 7.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 1.8 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.3 | 10.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 1.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 33.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 4.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 2.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 0.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 3.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 2.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 1.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 0.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 1.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 3.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.3 | 0.6 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.3 | 18.5 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.3 | 3.1 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.3 | 1.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 2.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.8 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 1.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 2.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 1.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 1.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 3.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 1.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 2.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 1.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 0.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.3 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 3.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 3.2 | GO:0015250 | water channel activity(GO:0015250) |
0.3 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 0.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 1.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 1.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 0.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 0.8 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.3 | 0.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 2.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 1.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 3.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 1.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 1.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 1.0 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.2 | 3.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 1.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 2.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 1.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.2 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 5.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 2.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 3.3 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 1.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.7 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 1.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 6.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 5.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 1.8 | GO:0034582 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 4.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.7 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.9 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 1.7 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 3.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 0.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.0 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 0.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 0.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 14.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.2 | 0.8 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.2 | 0.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 4.1 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 0.4 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.2 | 1.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 1.0 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 3.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.6 | GO:0018575 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 1.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 4.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 1.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 16.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 0.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 5.1 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 3.5 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 6.3 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 0.2 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.2 | 3.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 2.0 | GO:0017069 | snRNA binding(GO:0017069) |
0.2 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 1.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 3.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 1.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 1.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 4.9 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.2 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 1.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 1.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 5.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 2.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 2.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.2 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.2 | 1.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 0.7 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.2 | 0.5 | GO:0050664 | superoxide-generating NADPH oxidase activity(GO:0016175) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.2 | 0.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 0.6 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.2 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.2 | 1.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 112.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 4.2 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 2.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 1.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.3 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 0.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 6.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 2.6 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 1.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.3 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 2.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 1.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 3.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 2.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 2.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.7 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 1.0 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 1.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.7 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.9 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.7 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 15.1 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 1.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.3 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.9 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.6 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 3.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 1.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 2.8 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 3.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.5 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.1 | GO:0097617 | annealing activity(GO:0097617) |
0.1 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 3.1 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.5 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 4.3 | GO:0015399 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.1 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.1 | GO:0016418 | S-acetyltransferase activity(GO:0016418) dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.1 | 0.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 12.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 3.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 3.5 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 14.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 6.9 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 7.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.3 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.9 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 7.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 1.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 1.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 2.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 1.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.4 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 9.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 0.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.3 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.3 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.3 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 1.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.7 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 2.8 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 6.8 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 3.9 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 3.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 1.8 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 2.0 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 2.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.5 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 1.3 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 1.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.3 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.3 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.4 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.2 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.0 | 0.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.0 | 0.2 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.0 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.0 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 14.1 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.0 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.0 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 28.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.1 | 31.5 | PID IGF1 PATHWAY | IGF1 pathway |
1.1 | 52.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.0 | 8.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.0 | 24.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.0 | 10.9 | PID MYC PATHWAY | C-MYC pathway |
0.9 | 8.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.9 | 6.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.9 | 10.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 31.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.8 | 17.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.8 | 9.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.8 | 54.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.8 | 13.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.8 | 9.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 13.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.7 | 17.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.7 | 7.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.7 | 21.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.7 | 28.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.7 | 6.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 2.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.7 | 14.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.6 | 5.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 3.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 14.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.6 | 29.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.6 | 1.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.6 | 26.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.6 | 8.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 3.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.5 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.5 | 4.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 0.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 5.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 2.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 9.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.4 | 15.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 4.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 7.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 2.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 10.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 8.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 9.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 5.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.4 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 3.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 2.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 3.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 3.7 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.4 | 11.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.4 | 14.5 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 7.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 5.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 11.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 9.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 7.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 1.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 9.2 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 6.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 0.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 11.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 8.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 3.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 2.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 2.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 2.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 3.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 4.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 0.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 3.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 5.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 6.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 5.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 0.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 2.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 4.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 2.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 3.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 3.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 0.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 3.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 1.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 3.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.7 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.6 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 3.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 12.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.1 | 39.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
2.0 | 2.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.0 | 27.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.0 | 21.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.3 | 10.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.3 | 25.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.2 | 1.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.2 | 13.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.2 | 10.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.2 | 17.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.2 | 19.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.1 | 22.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.1 | 2.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.1 | 12.7 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
1.0 | 19.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
1.0 | 1.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.0 | 4.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.9 | 14.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.9 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.9 | 4.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.8 | 6.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.8 | 5.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 21.6 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.8 | 7.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.8 | 17.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.8 | 4.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.8 | 14.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.8 | 18.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.7 | 0.7 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.7 | 4.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 11.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.7 | 16.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.7 | 8.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.7 | 12.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 6.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.7 | 12.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.7 | 9.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.7 | 8.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.7 | 15.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.7 | 16.5 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.6 | 17.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.6 | 3.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 36.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.6 | 16.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.6 | 6.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.6 | 6.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.6 | 15.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 7.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 2.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.5 | 1.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.5 | 3.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.5 | 7.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 5.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.5 | 8.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 8.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.5 | 2.8 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.5 | 9.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.5 | 4.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.5 | 3.7 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.5 | 3.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.5 | 1.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 3.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.5 | 19.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 5.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 3.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 5.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 8.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 1.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 3.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.4 | 3.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 1.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 6.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 0.8 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.4 | 36.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 0.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 4.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 0.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.4 | 17.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 20.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 4.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 4.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 2.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 3.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 1.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 2.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 11.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 2.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 1.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 4.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 1.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 3.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 2.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 12.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 2.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 3.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 1.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 4.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 1.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 2.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 0.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 2.8 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.3 | 4.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 5.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 1.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 7.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 1.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 3.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 0.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 6.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 2.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 21.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 0.8 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 6.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 18.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 2.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 1.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 0.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 0.2 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.2 | 3.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 12.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 1.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 1.1 | REACTOME MAP KINASE ACTIVATION IN TLR CASCADE | Genes involved in MAP kinase activation in TLR cascade |
0.2 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 0.2 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.2 | 34.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 0.8 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.2 | 2.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 5.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 2.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 2.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 2.8 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 1.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 2.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 3.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 3.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 4.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 8.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 1.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 5.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 4.9 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 5.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 1.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 0.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 2.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 3.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.6 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 2.9 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 2.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.9 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.3 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 3.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.1 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 0.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 1.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 2.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.2 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
0.1 | 0.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 2.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 4.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 1.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.1 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.1 | REACTOME CELL CYCLE | Genes involved in Cell Cycle |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |